Ms. Brege served as executive vice president, corporate affairs for Onyx Pharmaceuticals until December 2011. In this role, Ms. Brege was responsible for the oversight of all external relationships including medical and scientific affairs, government affairs and public affairs.
Previously, Ms. Brege held the roles of chief operating officer and executive vice president and chief business officer for Onyx. In these roles, she oversaw the expansion of key corporate capabilities and strengthened the company’s financial position by significantly adding to its cash reserves. Prior to joining Onyx in 2006, Ms. Brege was a general partner at Red Rock Capital Management, a venture capital firm, and senior vice president and chief financial officer at COR Therapeutics. Ms. Brege earned her undergraduate degree from Ohio University and has an MBA from the University of Chicago.